PHIA Koninklijke Philips N.V.

Philips expands cloud-based enterprise imaging services to Europe for better access to AI-enabled workflows and innovation

Philips expands cloud-based enterprise imaging services to Europe for better access to AI-enabled workflows and innovation

February 27, 2025

Accelerating cloud adoption across Europe with Philips HealthSuite Imaging cloud services on Amazon Web Services

Amsterdam, The Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today the expansion of its cloud-based radiology informatics solutions to Europe, including exploring the use of generative AI to enhance radiology reporting. After the successful migration of over 150 sites in North and Latin America to HealthSuite Imaging on Amazon Web Services (AWS), Philips will offer these innovative cloud services across Europe [1, 2].

is a comprehensive cloud-based solution for radiology departments, managed by Philips and hosted on AWS. As a pure software-as-a-service model (SaaS), it includes regular upgrades, security patches and compliance checks, enabling healthcare institutions to secure their data, while allowing clinicians to access the latest innovations from any location.

Within three years, 95% of healthcare providers plan to migrate over half of their applications to the cloud [3]. With radiology exams available in the cloud, clinicians have secure, anytime, anywhere access to imaging studies and AI-enabled clinical and operational workflows, enhancing collaboration, speeding up clinical decisions, and improving patient care. In addition, remote access to scheduling, diagnostic reading and integrated reporting helps clinicians quickly adopt new capabilities, and healthcare organizations to improve operational efficiency and reduce IT management burdens.

“The availability of Philips’ cloud-based radiology solutions in Europe will be a game changer for healthcare providers, helping them to manage staff shortages, optimize workflows and drive better outcomes”, said Shez Partovi, Business Leader Enterprise Informatics at Philips. “The scalability and security of enterprise imaging in the cloud will enable radiology departments to benefit from the transformative power of generative AI and allow clinicians to focus on the most important aspect, bringing better care to more people.” 

AI Innovations and Future Prospects

One of the key benefits of cloud-based services is faster access to future innovations. Philips is exploring generative AI capabilities as part of its innovation strategy, focusing, for example, on conversational reporting to help healthcare providers face increased clinical demands and workforce shortages. These AI applications may reduce administrative burdens and time-consuming repetitive tasks, helping clinicians focus their expertise where it matters most – in critical decision-making. Philips aims to create robust and scalable generative AI applications that leverage state-of-the-art foundation models from Amazon Bedrock and seamlessly integrate into clinical workflows.

"Ambient reporting in radiology is just the beginning of using large language models in reporting”, said Dr. J.J. Visser, Radiologist and CMIO at Erasmus Medical Center. “It’s not only about speed; with fewer distractions from the reporting tool, I can focus more on image details and produce higher-quality reports in less time. I anticipate even greater advancements in the coming years.”





Find out more about Philips’ full radiology informatics portfolio at and in person from February 26 – March 1 at the European Congress of Radiology in Vienna, Austria.

[1] The following countries are currently included: Italy, UK, Belgium, Netherlands, France, Austria, Denmark, Ireland, Norway, Portugal, Spain, Sweden, Finland. 

[2] Cloud services (Philips HealthSuite Imaging) in EU are pending the approval of the notified body (DEKRA)

[3] Leonard. Michael. Accelerate healthcare transformation with cloud solutions | AWS Marketplace (amazon.com)

For further information, please contact:

Anna Hogrebe

Philips Global External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
27/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch